What is Organogenesis Holdings Inc.'s EV / EBITDA?

Organogenesis Holdings Inc. (ORGO) reported EV / EBITDA of 13.6× in Q1 2026.

What is the long-term trend for Organogenesis Holdings Inc.'s EV / EBITDA?

Over 3 years (2020 to 2025), Organogenesis Holdings Inc.'s EV / EBITDA has grown at a -26.4% compound annual growth rate (CAGR), from 27.4× to 10.9×.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Organogenesis Holdings Inc. ORGO EV / EBITDA

EV / EBITDA at other companies

IAR

Integra LifeSciencesIART

19.7×+3.6×

MiMedx GroupMDXG

8.7×-7.9×

BioventusBVS

8.4×-45.5×

ArtivionAORT

32.2×-2.2×

LeMaitre VascularLMAT

29.7×-0.3×

VericelVCEL

58.2×-506×

Other financials

Income statement

See full

Revenue$37.2M-57.1%

Gross profit$63.0M-22.5%

Operating income-$68.9M-158%

Net income-$53.2M-182%

EPS (diluted)-$0.44-159%

Balance sheet

See full

Cash & equivalents$91.4M-16.9%

Total debt$39.4M+24.8%

Total equity$244.6M+0.7%

Total assets$520.0M+11.3%

Cash flow

See full

Operating cash flow$21.1M+206%

CapEx$3.1M-13.2%

Free cash flow$18.0M+176%

Valuation

See full

Market cap$312.68M-23.7%

Enterprise value$260.72M-21.3%

P/E115×—

P/S0.6×-0.3×

Profitability

See full

Gross margin75.9%+0.8pp

Operating margin0.5%—

Net margin0.5%+0.3pp

FCF margin6.9%—

Returns & leverage

See full

Return on equity1.1%+0.6pp

Debt / equity0.2×0.0×

Current ratio3.5×-0.6×

Where this comes from

Calculated from Organogenesis Holdings Inc.’s reported figures.

enterprise value/ebitda=13.6×

Based on the most recent quarter.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s EV / EBITDA?: Organogenesis Holdings Inc. (ORGO) reported EV / EBITDA of 13.6× in Q1 2026.
What is the long-term trend for Organogenesis Holdings Inc.'s EV / EBITDA?: Over 3 years (2020 to 2025), Organogenesis Holdings Inc.'s EV / EBITDA has grown at a -26.4% compound annual growth rate (CAGR), from 27.4× to 10.9×.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.